Pediatrix Medical Group (MEX:MD) Cyclically Adjusted PS Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MD Pediatrix Medical Group Inc MEX:MD
52 GF Score
Price MXN447.00
GF Value MXN171.07
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Pediatrix Medical Group Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pediatrix Medical Group  (MEX:MD) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Pediatrix Medical Group Cyclically Adjusted PS Ratio Related Terms


Pediatrix Medical Group Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Pediatrix Medical Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pediatrix Medical Group Cyclically Adjusted PS Ratio Chart

Pediatrix Medical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.95 0.85 0.24 0.45 0.52

Pediatrix Medical Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.46 0.51 0.51 0.51

MEX:MD vs ADUS, GRDN, ASTH: Cyclically Adjusted PS Ratio Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pediatrix Medical Group Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's Cyclically Adjusted PS Ratio falls into.


MEX:MD
52GF Score
Pediatrix Medical Group Inc MEX:MD
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pediatrix Medical Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Pediatrix Medical Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Pediatrix Medical Group's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=104.224/333.9520*333.9520
=104.224

Current CPI (Jun. 2026) = 333.9520.

Pediatrix Medical Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 166.733 241.428 230.631
201612 176.584 241.432 244.253
201703 182.134 243.801 249.482
201706 168.477 244.955 229.688
201709 166.836 246.819 225.733
201712 185.337 246.524 251.065
201803 170.797 249.554 228.560
201806 179.460 251.989 237.832
201809 176.341 252.439 233.282
201812 199.551 251.233 265.254
201903 189.890 254.202 249.464
201906 128.971 256.143 168.149
201909 107.222 256.759 139.458
201912 106.011 256.974 137.767
202003 106.824 258.115 138.210
202006 116.077 257.797 150.367
202009 121.414 260.280 155.780
202012 101.573 260.474 130.226
202103 106.379 264.877 134.121
202106 110.203 271.696 135.455
202109 114.686 274.310 139.622
202112 119.740 278.802 143.426
202203 115.782 287.504 134.487
202206 113.827 296.311 128.287
202209 119.815 296.808 134.809
202212 121.968 296.797 137.237
202303 111.285 301.836 123.126
202306 107.179 305.109 117.311
202309 104.226 307.789 113.086
202312 105.485 306.746 114.841
202403 101.029 312.332 108.022
202406 104.346 314.175 110.914
202409 114.479 315.301 121.251
202412 117.571 315.605 124.406
202503 109.506 319.799 114.352
202506 107.035 322.561 110.815
202509 107.267 324.800 110.289
202512 107.058 324.054 110.328
202603 100.656 330.213 101.796
202606 104.224 333.952 104.224

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Pediatrix Medical Group (MEX:MD) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of MXN447.00 is trading 161.3% above its estimated GF Value™ of MXN171.07. GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.

Key valuation signals for MEX:MD:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: MXN171.07 vs. price of MXN447.00 (161.3% above fair value)
  • GF Score™: 52/100 with 7 warning signs

No single metric tells the full story. See the MEX:MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pediatrix Medical Group Business Description

Other Exchanges MD:USAPDC:Germany
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
52GF Score

Get the complete analysis for MEX:MD

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN447.00
Price
MXN171.07
GF Value